Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.

Oncotarget - 28 Feb 2017

Shang Chao, Sun Lin, Zhang Jiale, Zhao Bochao, Chen Xiuxiu, Xu Huimian, Huang Baojun

Abstract excerpt

Cancer Susceptibility Candidate 9 (CASC9) is a novel gene generating long non-coding RNA (lncRNA) with oncogenic potential that was first identified in esophageal cancer. In this study, we have found that CASC9 was overexpressed in gastric cancer (GC) compared to normal gastric tissue. A higher expression level was associated with aggressive pathological characteristics, including deep invasion, poor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Cell Movement

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Doxorubicin

Share to Drug Resistance, Neoplasm

Share to Gene Silencing

Share to Paclitaxel

Share to RNA, Long Noncoding

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 28146436
DOI: 10.18632/oncotarget.14871
PMCID: PMC5362493

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.PMID 28146436Read ↗

Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancerSemantic proximity Read ↗

LncRNA CASC9 promotes tumorigenesis by affecting EMT and predicts poor prognosis in esophageal squamous cell cancer.Semantic proximity Read ↗

Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer TreatmentSemantic proximity Read ↗

LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathwaySemantic proximity Read ↗

Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2Semantic proximity Read ↗

Long non-coding RNA CASC8 polymorphisms are associated with the risk of esophageal cancer in a Chinese population.Semantic proximity Read ↗

LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5pSemantic proximity Read ↗

LncRNA CASC19 contributed to the progression of pancreatic cancer through modulating miR-148b/E2F7 axis.Semantic proximity Read ↗

Curcumin inhibits the growth and invasion of gastric cancer by regulating long noncoding RNA AC022424.2Semantic proximity Read ↗

Genetic variant in 8q24 is associated with prognosis for gastric cancer in a Chinese population.Semantic proximity Read ↗

High expression of LncRNA CASC15 is a risk factor for gastric cancer prognosis and promote the proliferation of gastric cancer.Semantic proximity Read ↗

Overexpressed LncRNA ADAMTS9-AS2 inhibited gastric cancer (GC) development and sensitized chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.